What is the recommended acute and secondary management of an adult with a thrombotic cerebrovascular accident (ischemic stroke)?

Acute Management of Thrombotic CVA (Ischemic Stroke)

For adults with acute ischemic stroke, immediately administer IV alteplase (0.9 mg/kg, max 90 mg) if presenting within 4.5 hours of symptom onset and no contraindications exist, followed by mechanical thrombectomy for large vessel occlusions within 24 hours, then initiate aspirin 160-300 mg within 24-48 hours (delayed 24 hours post-thrombolysis). 1, 2

Hyperacute Phase (0-24 Hours)

Immediate Reperfusion Therapy

IV Thrombolysis:

• Administer IV alteplase 0.9 mg/kg (max 90 mg) as 10% bolus over 1 minute, then 90% infusion over 60 minutes for patients within 3 hours of last known well 1
• Extended window (3-4.5 hours): Same dosing regimen is recommended, though original ECASS-III excluded octogenarians, patients on warfarin, those with diabetes plus prior stroke history, and NIHSS >25 1
• The 2026 guideline updates thrombolytic eligibility criteria and contraindications 2

Mechanical Thrombectomy:

• Perform within 24 hours for large vessel occlusions - this represents the major advance expanding the therapeutic window 3
• Stent retrievers are first-line over intra-arterial thrombolysis 1
• Decision requires clinical assessment, non-contrast CT, and CT angiography showing large vessel occlusion; some patients need additional neuroimaging 3

Critical Physiologic Monitoring

Blood Pressure Management:

• Pre-thrombolysis: Reduce BP to <185/110 mm Hg before IV alteplase 4
• Post-thrombolysis: Maintain <180/105 mm Hg for first 24 hours 4
• No thrombolysis: Cautiously reduce only if >220/120 mm Hg, by no more than 20% over 24 hours 4
• Intensive BP lowering to <140 mm Hg systolic is NOT recommended in acute phase 4

Blood Glucose:

• Target 140-180 mg/dL during first 24 hours to prevent worse outcomes associated with hyperglycemia 1
• Treat hypoglycemia (<60 mg/dL) immediately 1

Oxygenation:

• Maintain oxygen saturation >94% - supplemental oxygen only if hypoxic, not routinely 4

Temperature:

• Monitor closely - both hypothermia (<37°C) and hyperthermia (>39°C) in first 24 hours increase mortality risk 1
• Induced hypothermia is NOT recommended outside clinical trials 1

Early Secondary Prevention (24-48 Hours)

Antiplatelet Therapy

Standard Stroke:

• Initiate aspirin 160-300 mg within 24-48 hours after stroke onset 1
• Delay aspirin 24 hours post-thrombolysis unless compelling concomitant indication exists 1
• Aspirin is NOT a substitute for thrombolysis or thrombectomy in eligible patients 1

Minor Stroke:

• Dual antiplatelet therapy (aspirin + clopidogrel) for 21 days started within 24 hours provides benefit for early secondary prevention up to 90 days 1
• Ticagrelor is NOT recommended over aspirin for minor stroke 1

Contraindicated Therapies

• Abciximab and other glycoprotein IIb/IIIa antagonists are potentially harmful and should not be used 1
• Tirofiban and eptifibatide efficacy is not well established 1

Acute Stroke Unit Care

All patients should be admitted to a dedicated stroke unit within 3 hours of onset - this consistently improves mortality, independence, and home discharge at 1 year 4. Benefits stem from specialized interprofessional team expertise, standardized protocols, early mobilization, and complication prevention 4.

Essential Nursing Assessments

Monitor the "main 5 vital signs" with frequency determined by patient status:

• Mental status/level of consciousness
• Blood pressure
• Breathing effort (rate, pattern, chest expansion)
• Oxygen saturation
• Body temperature

Perform bedside dysphagia screening before any oral intake 4

Key Clinical Pitfalls

1. Time is brain: The therapeutic window extends to 24 hours for mechanical thrombectomy, but earlier treatment yields better outcomes 3, 2

2. Don't substitute aspirin for reperfusion: Aspirin cannot replace thrombolysis or thrombectomy in eligible patients 1

3. Avoid aggressive BP lowering: Intensive reduction to <140 mm Hg systolic worsens outcomes; be cautious and gradual 4

4. Don't delay thrombolysis for consent: When patients cannot consent (aphasia, confusion) and no proxy is immediately available, proceed with IV alteplase in eligible patients with disabling stroke 1

5. Lower alteplase doses are inferior: The 0.6 mg/kg dose was NOT equivalent to standard 0.9 mg/kg dosing 1

Risk of Recurrence

Reperfusion therapy (EVT ± IV thrombolysis) does NOT increase early recurrent stroke or non-stroke thrombotic events within 90 days compared to medical management alone 5. This addresses a common concern about initiating acute therapies.